Clinical Trials Browser

Phase 3 × Active not recruiting × Idarubicin × Clear all

NCT05177731 2024-10-03

Venetoclax + Decitabine vs. "7+3" Induction Chemotherapy in Young AML

Phase 3 Active not recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute